Lower Tumor Burden Associated With Improved ORR With Liso-Cel in R/R CLL/SLL
Dr Samarasinghe on the Feasibility of First-Line Blinatumomab in Down Syndrome B-ALL
Dr Trudel on Results From the DREAMM-7 Trial of BVd in R/R Multiple Myeloma
Zanubrutinib Associated With Cost Savings and QALY Benefits vs Acalabrutinib in B-Cell Malignancies